6.68MMarket Cap-1262P/E (TTM)
1.550High1.310Low227.62KVolume1.310Open1.360Pre Close330.47KTurnover5.29%Turnover RatioLossP/E (Static)4.48MShares4.50052wk High1.12P/B6.41MFloat Cap0.84152wk Low--Dividend TTM4.30MShs Float19.500Historical High--Div YieldTTM17.65%Amplitude0.841Historical Low1.451Avg Price1Lot Size
Silo Pharma Stock Forum
Update
$Silo Pharma (SILO.US)$ Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Silo Pharma Announces Partnership With Global Cro for Central Nervous System Homing Peptide
Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company, announced that it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. This collaboration is particularly focused on the advancement of Silo's lead candidate, SPC-15, an intranasal prophylactic treatment for post-...
this is one they call “gotcha!”
No comment yet